This session will review little-known, emerging obesity pharmacotherapy and medical device pathways. You will have the opportunity to learn both the clinical and basic science that has led to the development of these treatment approaches, as well as the next steps and challenges for bringing the product to market. Attendees can look forward to learning about potential novel targets from both human and animal data.

You won’t want to miss this one-of-a-kind session free to all registered attendees of the ObesityWeek scientific sessions.

1:45pm Gastric Balloons
Jaime Ponce, MD FASMBS
2:00pm Intestinal Magnets
Christopher C Thompson, MD MSc
2:15pm FDA Device Section
Cynthia L Long, MD
2:45pm B3 Agonists
Aaron M Cypess, MD PhD MMSc
3:00pm MetAp2 Inhibition for Treatment of Metabolic Diseases
Kristin Taylor, PHD